Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Baxter International Inc.    BAX

BAXTER INTERNATIONAL INC.

(BAX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/26/2020 06/29/2020 06/30/2020 07/01/2020 07/02/2020 Date
84.31(c) 84.23(c) 86.1(c) 87.31(c) 87.21(c) Last
3 654 572 3 412 618 3 343 733 2 755 907 2 536 758 Volume
-1.20% -0.09% +2.22% +1.41% -0.11% Change
More quotes
Financials (USD)
Sales 2020 11 711 M - -
Net income 2020 1 595 M - -
Net Debt 2020 1 294 M - -
P/E ratio 2020 29,1x
Yield 2020 1,06%
Sales 2021 12 343 M - -
Net income 2021 1 857 M - -
Net Debt 2021 611 M - -
P/E ratio 2021 24,0x
Yield 2021 1,20%
Capitalization 44 376 M 44 376 M -
EV / Sales 2020 3,90x
EV / Sales 2021 3,64x
Nbr of Employees 50 000
Free-Float 74,3%
More Financials
Company
Baxter International specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - kidney dialysis drugs and equipment (52.1%); - systems for delivering medications and intravenous therapy (24.6%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral... 
More about the company
Surperformance© ratings of Baxter International Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on BAXTER INTERNATIONAL INC.
06/25BAXTER INTERNATIONAL : Moms on Watch troubled by mounting allegations at Prolact..
AQ
06/25BAXTER INTERNATIONAL : Publishes 2019 Corporate Responsibility Report, Highlight..
BU
06/11BAXTER INTERNATIONAL : Highlights New Data on the Role Technologies Play in Impr..
AQ
06/10BAXTER INTERNATIONAL : Highlights New Data on the Role Technologies Play in Impr..
BU
06/04BAXTER INTERNATIONAL INC. : Ex-dividend day for
FA
06/02BAXTER INTERNATIONAL : to Present at the Goldman Sachs 41st Annual Global Health..
BU
05/21BAXTER INTERNATIONAL : Receives CE Marking and Australian Regulatory Approval fo..
AQ
05/20BAXTER INTERNATIONAL : Receives CE Marking and Australian Regulatory Approval fo..
BU
05/06BAXTER INTERNATIONAL : Announces Results of Clinical Trial on Benefits of Dynami..
BU
05/05BAXTER INTERNATIONAL : Raises Quarterly Dividend by 11.4%
DJ
05/05BAXTER INTERNATIONAL : Increases Dividend and Declares Quarterly Dividend
BU
05/03Sustainable ETF Tries an Active Approach -- Journal Report
DJ
04/30BAXTER INTERNATIONAL : Management's Discussion and Analysis of Financial Conditi..
AQ
04/30BAXTER : 1Q Earnings Snapshot
AQ
04/30BAXTER INTERNATIONAL INC : Results of Operations and Financial Condition, Financ..
AQ
More news
News in other languages on BAXTER INTERNATIONAL INC.
06/25BAXTER INTERNATIONAL : Moms on Watch troubled by mounting allegations at Prolact..
06/25BAXTER INTERNATIONAL : Publishes 2019 Corporate Responsibility Report, Highlight..
06/11BAXTER INTERNATIONAL : Highlights New Data on the Role Technologies Play in Impr..
06/10BAXTER INTERNATIONAL : Highlights New Data on the Role Technologies Play in Impr..
06/04BAXTER INTERNATIONAL INC. : Ex-dividend day for
More news
Chart BAXTER INTERNATIONAL INC.
Duration : Period :
Baxter International Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAXTER INTERNATIONAL INC.
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 95,76 $
Last Close Price 87,21 $
Spread / Highest target 20,4%
Spread / Average Target 9,81%
Spread / Lowest Target -16,3%
EPS Revisions
Managers
NameTitle
José E. Almeida Chairman, President & Chief Executive Officer
James K. Saccaro Chief Financial Officer & Executive Vice President
Paul E. Martin Chief Information Officer & Vice President
Sumant Ramachandra Senior VP, Chief Science & Technology Officer
John D. Forsyth Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
BAXTER INTERNATIONAL INC.4.29%44 376
MEDTRONIC PLC-17.88%124 955
DEXCOM, INC.86.23%37 617
HOYA CORPORATION0.57%36 634
TERUMO CORPORATION5.74%28 745
ZIMMER BIOMET HOLDINGS-19.42%24 942